Approximately a quarter of Medicare Advantage prescription drug plan members with geographic atrophy also have wet AMD.

These glasses allow people with macular degeneration to see complete objects by banishing pesky blind spots using dozens of ...

While much attention is given to the painful crises, anaemia, and organ damage caused by SCD, its impact on vision is equally ...

In the 5 patients with bilateral geographic atrophy (GA) who received a K8 implant in 1 eye, there was a mean reduction in GA ...

City Therapeutics will develop a novel RNAi clinical candidate toward a specific disease target for intravitreal ...

In this video, Clement K. Chan, MD, FACS, discusses highlights from the AAO meeting, including presentations on pegcetacoplan and avacincaptad pegol for the treatment of geographic atrophy.In addition ...

Dr. Frenkel highlights a comprehensive program that covers the latest breakthroughs in glaucoma and cataract surgery to in-depth discussions on AI, retinal treatments, and new drug-delivery platforms, ...

PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces it has submitted a ...

The following is a summary of “Effect of siponimod on retinal thickness, a marker of neurodegeneration, in participants with ...

City Therapeutics has inked a new deal with Bausch + Lomb for a gene silencing approach to the eye disorder geographic ...

City Therapeutics, Inc., a privately held biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine, today announced that it has entered into a strategic collaboration ...

Certain imaging biomarkers and demographic factors are associated with geographic atrophy growth rate and may guide the selection of patients for the use of newer therapeutics. Visit us on Facebook.